Shopify CEO: Capitalizing on Cannabis | Wrathful Money | CNBC
E-commerce vacation gross sales reached modern heights in 2018, pulling in $126 billion. Jim Cramer talks to the COO of Shopify to search out out what’s next for the online…
Green Thumb Industries Founder: Moat Spherical Marijuana? | Inflamed Money | CNBC
Looking to web in on the cannabis craze? Jim Cramer’s eyeing a participant within the space on a weed-to-know basis. Don’t scramble away out his outlandish interview with Green Thumb…
Green Development Brands CEO: Breaking into Hashish Retail | Angry Money | CNBC
He’s spent time in the C-Suite at Victoria’s Secret and DSW, and now, he’s turning his attention to cannabis. Jim Cramer finds out what outlets can bring to the table…
Tilray CEO: ‘Hedging’ with Cannabis | Enraged Money | CNBC
Focus on reefer madness. Jim Cramer sits down with the CEO one of primarily the most up up to now stocks in the cannabis web site, Tilray, to appreciate if…
Cloak Remark CEO: Hashish in Canada | Angry Money | CNBC
Nothing will get your portfolio excessive delight in marijuana shares, however, to be completely blunt, Jim Cramer wonders if the easy cash’s been made. Don’t fling over his irregular with…
Brink’s CEO: Canadian marijuana legalization | Furious Cash | CNBC
Add Brink’s to the list of doable companies that would spruce up in the pot change. Don’t leave out Jim Cramer’s unique with CEO Douglas Pertz to search out out…
Acreage Holdings CEO: Cannabis Alternate ‘Warchest’ | Excited Money | CNBC
This firm’s board entails inclined Home Speaker John Boehner and a inclined Canadian prime minister. What brought them together? Weed. Make no longer omit Jim Cramer’s new with Acreage Holdings.»…
Inexperienced Thumb Industries CEO: ‘Credentializing’ Cannabis | Aroused Money | CNBC
The final hashish cohort has been smoking sizzling, but now no longer all pot shares are created equal. Jim Cramer checks in with the CEO of development-centered Inexperienced Thumb Industries…
Trulieve CEO: Clinical Hashish Transition | Angry Money | CNBC
It’s a medical marijuana company helping over 80,000 patients and also you may most doubtless well most doubtless most doubtless also have never heard of it. Jim Cramer looks into…